There’s no easier way to earn your continuing medical education credits than by visiting The Doctor’s Channel and watching a short, informative, and CME-accredited video.
Recent evidence has suggested that B-cells and humoral immunity play a key role in MS pathogenesis, which will lead to the development of new treatment options for multiple sclerosis patients. Emerging information on disease modifying therapies (DMTs) holds promise for transformative treatment of multiple sclerosis. It is critical that clinicians be aware of the safety, efficacy, and tolerability data associated with existing and investigational agents. This CME activity explores new findings in MS pathology and treatment, and will explore notable differences in the disease and management of patients with progressive forms of MS.